Condition (MeSH)
Tinea Capitis
ClinicalTrials.gov lists 15 trials for Tinea Capitis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
15 of the 15 trials are tagged with Tinea Capitis itself; the rest are tagged with a narrower condition beneath it.
When did Tinea Capitis trials start? (9)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2/3
- Phase 3
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 4 |
| 2021 | 1 |
| 2019 | 1 |
| 2015 | 2 |
| 2005 | 1 |
| 2004 | 2 |
| 2003 | 1 |
| 2002 | 1 |
No forecast is made for this condition: it averages 1.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 15 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Tinea Capitis trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Phase 2/3 | 2 |
| Phase 3 | 3 |
| Not applicable | 5 |
| Observational | 4 |
How many Tinea Capitis trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Completed | 10 |
| Withdrawn | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Tinea Capitis trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Merz North America, Inc. | 1 |
| Novartis | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer | 1 |
Which drugs are being tested for Tinea Capitis? (4)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| TERBINAFINE HYDROCHLORIDE (1%) | 3 |
| Itraconazole | 2 |
| Griseofulvin | 1 |
| Albendazole | 1 |
Interventions as named in the registry (6)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| oral griseofulvin, selenium sulfide shampoo 1%, ciclopirox shampoo , ketoconazole shampoo 2%, baby shampoo | 1 |
| Probiotic | 1 |
| Terbinafine Tablets | 1 |
| Fluconazol | 1 |
| Amphotericine in liposome (Ambisome®) | 1 |
Showing 5 of 6 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Tinea Capitis? (10)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Trichoscopy in paediatric patients with tinea capitis: a useful method to differentiate from alopecia areata. | Journal of the European Academy of Dermatology and Venereology : JEADV | 2014 | Yes |
| Corkscrew hair: a new dermoscopic sign for diagnosis of tinea capitis in black children. | Archives of dermatology | 2011 | Yes |
| [Dermoscopic pattern in tinea capitis]. | Revista iberoamericana de micologia | 2010 | Yes |
| Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials. | Journal of the American Academy of Dermatology | 2008 | Yes |
| Comma hairs: a dermatoscopic marker for tinea capitis: a rapid diagnostic method. | Journal of the American Academy of Dermatology | 2008 | Yes |
Showing 5 of 10 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.